Compass Therapeutics Inc Sustainability Reports
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The company develops proprietary antibody-based therapeutics designed to engage the human immune system to treat cancer and other diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00LPXKF34
6 reports from 2020 to 2025
Company Profile
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The company develops proprietary antibody-based therapeutics designed to engage the human immune system to treat cancer and other diseases.
Reports
6 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
